Allen LV Jr (2019) Mupirocin 1% in normal saline nasal suspension. US Pharmacist 44: 47-48.

Andrade M, Oliveira K, Morais C, Abrantes P, Pomba C, Rosato AE, Couto I, Costa SS (2022) Virulence potential of biofilm-producing Staphylococcus pseudintermedius, Staphylococcus aureus and Staphylococcus coagulans causing skin infections in companion animals. Antibiotics 11: 1339-1354.

Azzariti S, Bond R, Loeffler A, Zendri F, Timofte D, Chang YM, Pelligand L (2022) Investigation of In vitro susceptibility and resistance mechanisms in skin pathogens: perspectives for fluoroquinolone therapy in canine pyoderma. Antibiotics 11: 1204-1217.

Bajwa J (2016) Canine superficial pyoderma and therapeutic considerations. Can Vet J 57: 204-206.

Bakkiyaraj D, Sritharadol R, Padmavathi AR, Nakpheng T, Srichana T (2017) Anti-biofilm properties of a mupirocin spray formulation against Escherichia coli wound infections. Biofouling 33: 591-600.

Bannoehr J, Guardabassi L (2012) Staphylococcus pseudintermedius in the dog: taxonomy, diagnostics, ecology, epidemiology and pathogenicity. Vet Dermatol 23: 253-266.

Baumer W, Bizikova P, Jacob M, Linder KE (2017) Establishing a canine superficial pyoderma model. J App Microbiol 122: 331-337.

Gangwar A, Kumar P, Singh R, Kush P (2021) Recent advances in mupirocin delivery strategies for the treatment of bacterial skin and soft tissue infection. Future Pharmacol 1: 80-103.

Ha KR, Psaltis AJ, Butcher AR, Wormald PJ, Tan LW (2008) In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis. Laryngoscope 118: 535-540.

Hillier A, Lloyd DH, Weese JS, Blondeau JM, Boothe D, Breitschwerdt E, Guardabassi L, Papich M, Rankin S, Turnidge JD, Sykes JE (2014) Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis (Antimicrobial guidelines working group of the international society for companion animal infectious diseases). Vet Dermatol 25: 163-175.

Ishikawa J, Horii T (2005) Effects of mupirocin at subinhibitory concentrations on biofilm formation in Pseudomonas aeruginosa. Chemotherapy 51: 361-362.

Jamal M, Ahmad W, Andleeb S, Jalil F, Imran M, Nawaz MA, Hussain T, Ali M, Rafiq M, Kamil MA (2018) Bacterial biofilm and associated infections. J Chin Med Assoc 81: 7-11.

Khoshnood S, Heidary M, Asadi A, Soleimani S, Motahar M, Savari M, Saki M, Abdi M (2019) A review on mechanism of action, resistance, synergism, and clinical implications of mupirocin against Staphylococcus aureus. Biomed Pharmacother 109: 1809-1818.

Kizerwetter-Świda MK, Chrobak-Chmiel D, Rzewuska M (2019) High-level mupirocin resistance in methicillin-resistant Staphylococci isolated from dogs and cats. BMC Vet Res 15: 1-5

Lynch SA, Helbig KJ (2021) The complex diseases of Staphylococcus pseudintermedius in canines: where to next? Vet Sci 8: 11-29.

Meroni G, Filipe JF, Drago L, Martino PA (2019) Investigation on antibiotic-resistance, biofilm formation and virulence factors in multi drug resistant and non multi drug resistant Staphylococcus pseudintermedius. Microorganisms 7: 702-713.

Rosman CW, Mei van der HC, Sjollema J (2021) Influence of sub-inhibitory concentrations of antimicrobials on micrococcal nuclease and biofilm formation in Staphylococcus aureus. Sci Rep 11: 1-11.

Ruscher C, Lübke-Becker AL, Wleklinski CG, Soba A, Wieler LH, Walther B (2009) Prevalence of methicillin-resistant Staphylococcus pseudintermedius isolated from clinical samples of companion animals and equidaes. Vet Microbiol 136: 197-201.

Sanju AJ, Kopula SS, Palraj KK (2015) Screening for mupirocin resistance in Staphylococcus. J Clin Diagn Res 9: 9-10.

Silva V, Oliveria A, Manageiro V, Canica M, Contente D, Capita R, Alonso-Calleja C, Carvalho I, Capelo JL, Igrejas G, Poeta P (2021) Clonal diversity and antimicrobial resistance of methicillin-resistant Staphylococcus pseudintermedius isolated from canine pyoderma. Microorganisms 9: 482-491.

Singh A, Walker M, Rousseau J, Weese JS (2013) Characterization of the biofilm forming ability of Staphylococcus pseudintermedius from dogs. BMC Vet Res 9: 1-6.

Sritharadol R, Hamada M, Kimura S, Ishii Y, Srichana T, Tateda K (2018) Mupirocin at subinhibitory concentrations induces biofilm formation in Staphylococcus aureus. Microb Drug Resist 24: 1249-1258.

Sritharadol R, Nakpheng T, Heng PW, Srichana T (2017) Development of a topical mupirocin spray for antibacterial and wound-healing applications. Drug Dev Ind Pharm 43: 1715-1728.

Stefanetti V, Bietta A, Pascucci L, Marenzoni ML, Coletti M, Franciosini MP, Passamonti F, Proietti PC (2017) Investigation of the antibiotic resistance and biofilm formation of Staphylococcus pseudintermedius strains isolated from canine pyoderma. Vet Ital 53: 289-296.

Stewart PS (2002) Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 292: 107-113.

Stewart PS, Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358: 135-138.

Summers JF, Brodbelt DC, Forsythe PJ, Loeffler A, Hendricks A (2012) The effectiveness of systemic antimicrobial treatment in canine superficial and deep pyoderma: a systematic review. Vet Dermatol 23: 305-329.

Uren B, Psaltis A, Wormald PJ (2009) Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis. Laryngoscope 118: 1677-1680.

Valentine B (2019) Treating pyoderma without the use of systemic antibiotics. Can Vet J 60: 1361-1363.

Valentine BK, Dew W, Yu A, Weese JS (2012) In vitro evaluation of topical biocide and antimicrobial susceptibility of Staphylococcus pseudintermedius from dogs. Vet Dermatol 23: 493-e95.

Zhou S, Cui Z, Urban J (2011) Dead cell counts during serum cultivation are underestimated by the fluorescent live/dead assay. Biotechnol J 6: 513-518.